Paolo Guidetti passed away on December 28, 2007 at age 41, a victim of a brief, devastating bout with lymphoma. His death deprives the fi eld of tryptophan research of one of its brightest and most promising young stars. We also mourn the loss of a unique individual, who not only had an outstanding mind but possessed an exceptional ability to inspire and to foster collaborations and friendships.
Guidetti
International Journal of Tryptophan Research 2009:2 hypothesis, suggesting that neurodegeneration in HD is non-cell autonomous in nature. More specifi cally, Paolo's results indicated that the neurotoxic effects of mutant huntingtin, the protein that initiates the pathological cascade, might depend on the activation of microglial kynurenines. As a corollary, it became evident that interventions aimed at preventing or arresting the formation of microglial kynurenines might render the effects of the mutant protein less severe or even innocuous. At the time of his passing, Paolo had designed a number of imaginative genetic and pharmacological approaches to test this attractive hypothesis and its implications for the treatment of HD.
Paolo's discoveries and the development of his exciting concepts were a direct consequence of his ability to think creatively, his willingness to embark on technically demanding, high-risk projects, an impressive no-nonsense, "can-do" attitude, and-maybe most importantly-an uncanny ability to identify and pursue scientifi cally important questions. But there was far more to Paolo than talent and professional success. Regular attendees of ISTRY (International Society for Tryptophan Research) meetings will remember him as an energetic, lively and optimistic, and at the same time a kind and generous colleague, to list but a few of the adjectives used to describe Paolo in the many messages sent by mourners from all corners of the world.
Paolo's approach to life and people brought the best out in everyone, yet his fl ame shone far too briefl y. I will personally miss a wonderful scientifi c companion, who had a brilliant future ahead of him. There is apparent truth to the old saying that only the good die young. It was a privilege to have him in our lives. He will not be forgotten.
Robert Schwarcz, University of Maryland School of Medicine, Baltimore, MD (U.S.A).

